3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Neoplasms
5
Pancreatic Neoplasms
4
Ovarian Neoplasms
2
Wilms Tumor
1
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Rectal Neoplasms
1
Rare Diseases
1
Prostatic Neoplasms
1
Pancreatic Cyst
1
Neuroblastoma
1
Nervous System Neoplasms
1
Multiple Myeloma
1
Lymphoma
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Intestinal Neuroendocrine Tumor
1
Frailty
1
Financial Stress
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Cognitive Dysfunction
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Brain Neoplasms
1
Bone Neoplasms
1
Interventions
pembrolizumab
117
Carboplatin
104
Pemetrexed
93
Cisplatin
59
Paclitaxel
49
Drug Therapy
41
osimertinib
40
Nivolumab
40
Docetaxel
37
Specimen Handling
33
Magnetic Resonance Spectroscopy
28
Bevacizumab
26
durvalumab
22
Gemcitabine
22
cemiplimab
21
130-nm albumin-bound paclitaxel
21
Radiotherapy
20
tislelizumab
19
Radiosurgery
19
atezolizumab
17
aflutinib
15
Immunotherapy
15
Cetuximab
15
Platinum Compounds
13
Ipilimumab
13
Immune Checkpoint Inhibitors
13
Biopsy
12
Standard of Care
11
Surgical Procedures, Operative
10
Injections
10
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Carcinoma, Non-Small-Cell Lung
×
Data Collection
×
Clear all
NCT02622581
2025-02-18
CRISP
AIO-Studien-gGmbH
Recruiting
12,400 enrolled